M uneretto and colleagues 1 demonstrated excellent results in patients having total arterial compared with conventional arterial and venous grafting for coronary artery disease in a prospective randomized study. Free arterial grafts are being used increasingly to replace the saphenous vein as a conduit to avoid the late complications of vein graft atherosclerosis. The aim is to prevent major ischemic complications and reoperation. To date, increased complexity, safety, and efficacy concerns have limited the acceptance of extensive or complete arterial grafting. Symptom-directed angiography and late clinical follow-up suggest that the benefits of arterial versus venous grafting have become more obvious with time. Well-constructed and well-conducted prospective randomized controlled trials are therefore very important to define the benefits, if any, and which patients should receive only arterial grafts.
Muneretto and colleagues. 1 The exact numbers of the various grafts were not specified. The authors report a 100% patency (n ϭ 140) of the left ITA to the graft of the left anterior descending artery and a 1.4% (1/72) failure rate for the radial artery. A string sign developed in 7.5% (3/40) of right ITAs, and there was an 11% (15/137) failure rate for the saphenous vein. Most surgeons would regard the string sign as graft failure, thus increasing the total non-left anterior descending arterial graft failure rate to 3.6%. The difference in patency between the arterial venous saphenous grafts remains significant (P ϭ .04). Although the clinical results parallel those of the graft patency, critical analysis of the quality of the end points is essential. Cardiac event-free survival is only useful if the various events are robust. Recurrence of angina is a very weak end point, and nonfatal myocardial infarction requires careful definition. Graft occlusion, reintervention, and death are strong end points on which the trial outcome analyses should depend. The numbers of events that make up the composite end point are not documented. A more meaningful clinical analysis should exclude angina, which would improve the credibility of results but reduce the power of the statistics.
The criteria for accepting the radial artery as a conduit are important. Inadequate ulnar collateral circulation occurs in about 5% of patients, preventing the use of the radial artery. Disease in the radial artery is more common than in the ITA. 6 In elderly patients undergoing coronary artery bypass surgery, adaptive fibrointimal hyperplasia, calcification, and atheroma are common pathologic findings in radial arteries. Until the effect of these disease processes on graft function is defined, the use of radial arteries or ITAs with macroscopic disease is probably best avoided.
The findings of Muneretto and colleagues 1 are important and should be viewed in the context of the Radial Artery Patency Study 7 and the Radial Artery Patency and Clinical Outcomes 5-year interim results. 8 The Radial Artery Patency and Clinical Outcomes study confirms that right ITA and radial artery grafts in the non-left anterior descending artery position can be used safely; however, no benefits were detected at 5 years. The Radial Artery Patency Study compares the patency of the saphenous vein with that of the radial artery. A total of 526 patients have been entered in this study, and the early angiographic results will be reported shortly. 6 The longitudinal follow-up of patients over the next 10 years from these 3 studies will provide surgeons with valuable information about the patency of arterial compared with saphenous vein grafts and the clinical outcomes. Until that time, the hypothesis that total arterial grafting is superior to conventional arterial and venous grafting remains unproven.
